← Back to Trial

Saruparib in Combination With Physician’s Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

Trial Locations

• Research Site Hot Springs, Arkansas, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Springdale, Arkansas, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Beverly Hills, California, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Los Alamitos, California, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Los Angeles, California, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site San Diego, California, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Margate, Florida, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Miami, Florida, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Orlando, Florida, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Honolulu, Hawaii, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Chicago, Illinois, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Chicago, Illinois, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Elk Grove Village, Illinois, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Hinsdale, Illinois, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Ames, Iowa, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Baltimore, Maryland, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Baltimore, Maryland, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Towson, Maryland, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Detroit, Michigan, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Grand Rapids, Michigan, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Marshall, Minnesota, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Camden, New Jersey, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Albuquerque, New Mexico, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Shirley, New York, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Canton, Ohio, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Cincinnati, Ohio, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Portland, Oregon, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Portland, Oregon, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Greenville, South Carolina, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Aberdeen, South Dakota, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Mitchell, South Dakota, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Pierre, South Dakota, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Sioux Falls, South Dakota, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Yankton, South Dakota, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nashville, Tennessee, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Austin, Texas, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Dallas, Texas, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Fort Worth, Texas, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Longview, Texas, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Wichita Falls, Texas, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Salt Lake City, Utah, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Spokane, Washington, United States
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Graz, Austria
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Linz, Austria
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Salzburg, Austria
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Vienna, Austria
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Barretos, Brazil
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Brasília, Brazil
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Natal, Brazil
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Porto Alegre, Brazil
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site São Caetano do Sul, Brazil
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site São Paulo, Brazil
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site São Paulo, Brazil
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Calgary, Alberta, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Edmonton, Alberta, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Abbotsford British Columbia, British Columbia, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Brampton, Ontario, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kitchener, Ontario, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site North York, Ontario, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Ottawa, Ontario, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Toronto, Ontario, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Windsor, Ontario, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Greenfield Park, Quebec, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Montreal, Quebec, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Montreal, Quebec, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Saint-Jérôme, Quebec, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Saskatoon, Saskatchewan, Canada
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Beijing, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Changsha, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Chengdu, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Chengdu, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Chongqing, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Fuzhou, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Guangzhou, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Guangzhou, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Guiyang, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Jiaxing, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Jinan, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kunming, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kunming, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Lanzhou, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nanchang, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nanjing, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nantong, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Ningbo, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Qingdao, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Shandong, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Shanghai, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Shanghai, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Wenzhou, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Wuhan, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Wuhan, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Wuhan, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Xi'an, China
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Angers, France
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Caen, France
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Montpellier, France
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Paris, France
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Poitiers, France
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Bergisch Gladbach, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Berlin, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Berlin, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Bonn, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Cologne, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Dresden, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Duisburg, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Essen, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Frankfurt am Main, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Göttingen, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Hamburg, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Heidelberg, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Herne, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Mannheim, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Marburg, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Mettmann, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site München, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Münster, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nuremberg, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nürtingen, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Rostock, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Stuttgart, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Ulm, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Würzburg, Germany
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Hong Kong, Hong Kong
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Hong Kong, Hong Kong
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Budapest, Hungary
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Budapest, Hungary
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Budapest, Hungary
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Pécs, Hungary
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Szeged, Hungary
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Ansārinagar, India
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Bangalore, India
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Delhi, India
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kannur, India
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nagpur, India
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site New Delhi, India
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Vadodara, India
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Bari, Italy
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Genova, Italy
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Padova, Italy
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Rozzano, Italy
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Chiba, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Fukuoka, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Fukuoka, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Hiroshima, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kamakura-shi, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kawagoe-shi, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kisarazu-shi, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kita-gun, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kobe, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kumamoto, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Maebashi, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nagano, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nagasaki, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nagoya, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Nagoya, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Osaka, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Sakai, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Sakura-shi, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Sapporo, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Suita-shi, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Yokohama, Japan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Gdansk, Poland
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Koszalin, Poland
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Krakow, Poland
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Lodz, Poland
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Olsztyn, Poland
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Poznan, Poland
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Warsaw, Poland
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Wroclaw, Poland
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Rio Piedras, Puerto Rico
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Daegu, South Korea
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Goyang-si, South Korea
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Seoul, South Korea
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Seoul, South Korea
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Seoul, South Korea
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Seoul, South Korea
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Barcelona, Spain
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Barcelona, Spain
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Córdoba, Spain
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Las Palmas de Gran Canaria, Spain
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Madrid, Spain
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Madrid, Spain
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Santander, Spain
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Valencia, Spain
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Aarau, Switzerland
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Chur, Switzerland
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Kaohsiung City, Taiwan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Taichung, Taiwan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Tainan, Taiwan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Taipei, Taiwan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Taipei, Taiwan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Taoyuan, Taiwan
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Bangkok, Thailand
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Bangkok, Thailand
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Bangkok, Thailand
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Khlong Luang, Thailand
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Songkhla, Thailand
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Adana, Turkey (Türkiye)
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Ankara, Turkey (Türkiye)
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Ankara, Turkey (Türkiye)
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Cordaleo, Turkey (Türkiye)
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Istanbul, Turkey (Türkiye)
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Izmir, Turkey (Türkiye)
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Cambridge, United Kingdom
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Glasgow, United Kingdom
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site London, United Kingdom
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site London, United Kingdom
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Manchester, United Kingdom
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)
• Research Site Plymouth, United Kingdom
  • Contact: AstraZeneca Clinical Study Information Center · 1-877-240-9479 · [email protected] (opens in new tab)